Your Daily Women's Health Briefing
Reproductive health research, menopause science, maternal care, and the women's health investment boom. Get the latest women's health developments delivered to your inbox every morning. AI-powered, personalized, and grounded in real sources.
Global Consensus Renames PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS)
An international consensus panel has officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), a change published in The Lancet on May 12, 2026. This new terminology aims to better reflect the condition's underlying hormonal and metabolic features, improve diagnostic accuracy, and reduce stigma for the one in eight women affected globally.
Melinda French Gates has pledged a $250 million grant to support women's global health initiatives, as part of her broader $1 billion commitment to women and families worldwide. This significant investment addresses the persistent underfunding in women's health research and innovation, signaling a turning point in efforts to close existing evidence gaps.
Beyond breast cancer detection, mammograms are now being recognized for their ability to reveal hidden signs of heart disease. This lesser-known benefit allows for earlier identification of cardiovascular risks in women, leveraging an existing and widely utilized screening tool for broader health insights.
The Bottom Line
Recent developments highlight both a critical re-evaluation of women's health conditions and a renewed commitment to funding, alongside surprising new applications for existing diagnostic tools, collectively advancing understanding and care.
Get Women's Health in your inbox every morning
Join readers who start their day with an AI-powered briefing on women's health and the topics they care about most — fully sourced and ready in 5 minutes.
Start your free trial7-day free trial · No credit card required
Related Briefings
Public Health
Epidemiology, vaccine development, health policy, and global health challenges.
Biotechnology
Gene editing, drug development, clinical trials, and the science of engineering biology.
Pharmaceuticals
Drug approvals, clinical trials, pricing debates, and the pharmaceutical industry landscape.
Pick your topics
Women's Health, plus anything else you follow
We research overnight
AI synthesizes real-time sources while you sleep
Read in 5 minutes
Cited, structured, no fluff — in your inbox every morning